Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, et al. Recommendations for the use of WBC growth factors: american society of clinical oncology clinical practice guideline update. J Clin Oncol. 2015;33:3199–212.

Article  CAS  PubMed  Google Scholar 

D’Souza A, Jaiyesimi I, Trainor L, Venuturumili P. Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev. 2008;22:280–90.

Article  PubMed  Google Scholar 

Lee SY, Kim EK, Kim JY, Park TK, Choi SH, Im YH, et al. The incidence and clinical features of PEGylated filgrastim-induced acute aortitis in patients with breast cancer. Sci Rep. 2020;10:18647.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoshina H, Takei H. Granulocyte-colony stimulating factor-associated aortitis in cancer: a systematic literature review. Cancer Treat Res Commun. 2021;29: 100454.

Article  PubMed  Google Scholar 

Joseph G, Goel R, Thomson VS, Joseph E, Danda D. Takayasu Arteritis: JACC Focus Seminar 3/4. J Am Coll Cardiol. 2022. https://doi.org/10.1016/j.jacc.2022.09.051.

Article  PubMed  PubMed Central  Google Scholar 

Oshima Y, Takahashi S, Tani K, Tojo A. Granulocyte colony-stimulating factor-associated aortitis in the japanese adverse drug event report database. Cytokine. 2019;119:47–51.

Article  CAS  PubMed  Google Scholar 

Miller EB, Grosu R, Landau Z. Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF). Clin Rheumatol. 2016;35:1655–7.

Article  PubMed  Google Scholar 

Sato Y, Kaji S, Ueda H, Tomii K. Thoracic aortitis and aortic dissection following pegfilgrastim administration. Eur J Cardiothorac Surg. 2017;52:993–4.

Article  PubMed  Google Scholar 

Ito Y, Noda K, Aiba K, Yano S, Fujii T. Diffuse large B-cell lymphoma complicated with drug-induced vasculitis during administration of pegfilgrastim. Rinsho Ketsueki. 2017;58:2238–42.

PubMed  Google Scholar 

Kawahara H, Endo A, Yoshitomi H, Tanabe K. Recurrent granulocyte colony-stimulating factor-induced aortitis after pegfilgrastim administration. Circ Rep. 2020;2:764–5.

Article  PubMed  PubMed Central  Google Scholar 

Shirai T, Komatsu H, Sato H, Fujii H, Ishii T, Harigae H. Migratory aortitis associated with granulocyte-colony-stimulating factor. Intern Med. 2020;59:1559–63.

Article  PubMed  PubMed Central  Google Scholar 

Sasaki K, Miyauchi M, Ogura M, Shimura-Nukina A, Toyama K, Nakazaki K, et al. Arteritis after administration of granulocyte colony-stimulating factor: a case series. Int J Hematol. 2019;110:370–4.

Article  PubMed  Google Scholar 

Sasaki K, Matsuda K, Miyauchi M, Honda A, Shimura A, Masamoto Y, et al. A retrospective analysis on arteritis after administration of granulocyte colony-stimulating factor. Ann Hematol. 2021;100:1341–3.

Article  CAS  PubMed  Google Scholar 

Uemura Y, Oshima K, Fuseya A, Hosokai A, Ohashi A, Kanno M, et al. Aortitis after administration of pegfilgrastim to a healthy donor for peripheral blood stem cell collection. Int J Hematol. 2023. https://doi.org/10.1007/s12185-023-03649-0.

Article  PubMed  PubMed Central  Google Scholar 

Kimura A, Kitamura H, Date Y, Numano F. Comprehensive analysis of HLA genes in Takayasu arteritis in Japan. Int J Cardiol. 1996;54(Suppl):S61–9.

Article  PubMed  Google Scholar 

Umeda M, Ikenaga J, Koga T, Michitsuji T, Shimizu T, Fukui S, et al. Giant cell arteritis which developed after the administration of granulocyte-colony stimulating factor for cyclic neutropenia. Intern Med. 2016;55:2291–4.

Article  CAS  PubMed  Google Scholar 

Park MC, Lee SW, Park YB, Lee SK. Serum cytokine profiles and their correlations with disease activity in Takayasu’s arteritis. Rheumatology (Oxford). 2006;45:545–8.

Article  CAS  PubMed  Google Scholar 

Parodis I, Dani L, Notarnicola A, Martenhed G, Fernstrom P, Matikas A, et al. G-CSF-induced aortitis: two cases and review of the literature. Autoimmun Rev. 2019;18:615–20.

Article  CAS  PubMed  Google Scholar